Protara Therapeutics, Inc. (TARA) Ownership

$4.96

north_east
$0.74 (17.54%)
Day's range
$4.31
Day's range
$5.03

Protara Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JANUS HENDERSON GROUP PLC 11/14/2025 4.23 M $18.36 M   3.14% 10.01%
BLACKROCK, INC. 11/12/2025 2.23 M $9.70 M   3.99% 5.27%
VELAN CAPITAL INVESTMENT MANAGEMENT LP 11/14/2025 2.14 M $9.30 M   0.00% 5.06%
BLACKSTONE INC. 11/14/2025 1.91 M $8.31 M   0.00% 4.52%
VANGUARD GROUP INC 11/07/2025 1.90 M $8.28 M   5.67% 4.50%
ACORN CAPITAL ADVISORS, LLC 11/17/2025 1.75 M $7.62 M   0.00% 4.15%
CATALIO CAPITAL MANAGEMENT, LP 11/14/2025 1.50 M $6.53 M   -7.72% 3.55%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 11/14/2025 1.40 M $6.09 M   0.00% 3.31%
UBS GROUP AG 11/13/2025 843.07 K $3.67 M   -25.77% 1.99%
5AM VENTURE MANAGEMENT, LLC 11/14/2025 800.00 K $3.48 M   0.00% 1.89%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 758.72 K $3.30 M   1.91% 1.79%
MILLENNIUM MANAGEMENT LLC 11/14/2025 688.26 K $2.99 M   22.01% 1.63%
BAKER BROS. ADVISORS LP 11/14/2025 536.83 K $2.34 M   0.00% 1.27%
CITADEL ADVISORS LLC 11/14/2025 502.45 K $2.19 M   21.80% 1.19%
DRIEHAUS CAPITAL MANAGEMENT LLC 11/14/2025 444.44 K $1.93 M   100.00% 1.05%
STEMPOINT CAPITAL LP 11/14/2025 363.67 K $1.58 M   -68.20% 0.86%
SUPERSTRING CAPITAL MANAGEMENT LP 11/14/2025 360.00 K $1.57 M   0.00% 0.85%
STATE STREET CORP 11/14/2025 350.09 K $1.52 M   20.34% 0.83%
RENAISSANCE TECHNOLOGIES LLC 11/13/2025 314.30 K $1.37 M   110.66% 0.74%
ASSENAGON ASSET MANAGEMENT S.A. 10/07/2025 307.42 K $1.34 M   100.00% 0.73%
MARSHALL WACE, LLP 11/13/2025 285.59 K $1.24 M   -21.22% 0.68%
NUVEEN, LLC 11/12/2025 283.48 K $1.23 M   179.01% 0.67%
CIBC WORLD MARKET INC. 11/06/2025 274.99 K $1.20 M   -5.66% 0.65%
NORTHERN TRUST CORP 11/14/2025 234.36 K $1.02 M   -5.56% 0.55%
OPPENHEIMER & CO INC 11/06/2025 206.97 K $900.33 K   -15.89% 0.49%
BANK OF AMERICA CORP /DE/ 11/14/2025 180.48 K $785.07 K   -0.62% 0.43%
MORGAN STANLEY 11/14/2025 108.54 K $472.17 K   -15.80% 0.26%
GSA CAPITAL PARTNERS LLP 11/07/2025 101.49 K $441.00 K   8.99% 0.24%
J. GOLDMAN & CO LP 11/14/2025 100.35 K $436.52 K   -21.20% 0.24%
BANK OF NEW YORK MELLON CORP 11/03/2025 96.99 K $421.92 K   3.06% 0.23%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 95.77 K $416.62 K   0.00% 0.23%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 81.20 K $353.23 K   -63.07% 0.19%
AMERICAN CENTURY COMPANIES INC 11/12/2025 61.55 K $267.76 K   0.00% 0.15%
BNP PARIBAS ARBITRAGE, SNC 11/13/2025 50.46 K $219.48 K   -67.38% 0.12%
DIMENSIONAL FUND ADVISORS LP 11/12/2025 47.71 K $207.75 K   -44.07% 0.11%
BARCLAYS PLC 11/12/2025 45.52 K $198.01 K   -18.19% 0.11%
JANE STREET GROUP, LLC 11/14/2025 45.25 K $196.82 K   68.23% 0.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2025 44.83 K $195.01 K   -25.07% 0.11%
TRUIST FINANCIAL CORP 11/03/2025 40.00 K $174.00 K   0.00% 0.09%
BAILARD, INC. 10/30/2025 36.67 K $159.51 K   23.18% 0.09%
LPL FINANCIAL LLC 11/12/2025 36.05 K $156.82 K   3.00% 0.09%
ADAR1 CAPITAL MANAGEMENT, LLC 11/14/2025 35.22 K $153.22 K   -71.29% 0.08%
RHUMBLINE ADVISERS 11/06/2025 34.14 K $148.49 K   8.23% 0.08%
INVESCO LTD. 11/13/2025 25.17 K $109.49 K   5.16% 0.06%
WELLS FARGO & COMPANY/MN 11/13/2025 24.77 K $107.73 K   19.48% 0.06%
MAREX GROUP PLC 11/14/2025 22.25 K $96.79 K   100.00% 0.05%
PRELUDE CAPITAL MANAGEMENT, LLC 11/14/2025 21.52 K $93.60 K   -5.70% 0.05%
WOLVERINE TRADING, LLC 11/14/2025 20.00 K $88.20 K   -35.90% 0.05%
NEW YORK STATE COMMON RETIREMENT FUND 11/03/2025 19.70 K $85.70 K   -41.37% 0.05%
TWO SIGMA INVESTMENTS, LP 11/14/2025 19.56 K $85.08 K   35.78% 0.05%

Protara Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 93 institutional investors and hedge funds held shares of Protara Therapeutics, Inc.. The most heavily invested institutionals were:

JANUS HENDERSON GROUP PLC: 4.23 M

BlackRock, Inc.: 2.23 M

Velan Capital Investment Management LP: 2.14 M

Blackstone Inc.: 1.91 M

VANGUARD GROUP INC: 1.9 M

ACORN CAPITAL ADVISORS, LLC: 1.75 M

62.00% of Protara Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 27.48 M shares in the last 24 months. This purchase volume represents approximately $136.28 M in transactions.